Detalles de la búsqueda
1.
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.
Lancet Oncol
; 21(11): 1443-1454, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152284
2.
Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients.
Breast Cancer Res
; 22(1): 2, 2019 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892336
3.
ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
PLoS Genet
; 7(4): e1001382, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21552322
4.
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
Lancet Oncol
; 14(11): 1067-1076, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24035531
5.
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers.
Nat Commun
; 14(1): 4017, 2023 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37419892
6.
Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast Cancer.
JNCI Cancer Spectr
; 2(2): pky005, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31360844
7.
Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation.
Nat Commun
; 7: 13294, 2016 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27827358
8.
The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes.
Eur J Endocrinol
; 161(2): 307-15, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19460888
Resultados
1 -
8
de 8
1
Próxima >
>>